Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19
Keyword(s):
An exacerbated and unbalanced immune response may account for the severity of COVID-19, the disease caused by the novel severe acute respiratory syndrome (SARS) coronavirus 2, SARS-CoV-2. In this Viewpoint, we summarize recent evidence for the role of neutrophils in the pathogenesis of COVID-19 and propose CXCR2 inhibition as a promising treatment option to block neutrophil recruitment and activation.
2011 ◽
Vol 2011
◽
pp. 1-12
◽
Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic
2021 ◽
Vol 9
◽
pp. 251513552110597
Keyword(s):
Keyword(s):
2021 ◽
pp. 43-57
Keyword(s):
2021 ◽
Keyword(s):